Gabapentin evoked changes in functional activity in nociceptive regions in the brain of the anaesthetized rat: An fMRI study

British Journal of Pharmacology

Volumn 153, Issue 7, 2008, Pages 1558-1567

  Governo, R J M ^a,b   Morris, P G ^a   Marsden, C A ^a   Chapman, V ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

BOLD; fMRI; Gabapentin; Periaqueductal grey; SPM99; Thalamus

Indexed keywords

GABAPENTIN; SODIUM CHLORIDE;

AMYGDALOID NUCLEUS; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ARTICLE; BRAIN FUNCTION; BRAIN REGION; BREATHING RATE; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG MECHANISM; ELECTROENCEPHALOGRAM; ENTORHINAL CORTEX; FUNCTIONAL MAGNETIC RESONANCE IMAGING; MEAN ARTERIAL PRESSURE; NERVE CONDUCTION; NOCICEPTION; NONHUMAN; OXYGEN BLOOD LEVEL; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; RAT; THALAMUS;

ADMINISTRATION, ORAL; AMINES; ANALGESICS; ANIMALS; BLOOD PRESSURE; BRAIN; BRAIN MAPPING; CYCLOHEXANECARBOXYLIC ACIDS; DISEASE MODELS, ANIMAL; GAMMA-AMINOBUTYRIC ACID; INFUSIONS, INTRAVENOUS; MAGNETIC RESONANCE IMAGING; OXYGEN; PAIN; PAIN MEASUREMENT; RATS; RATS, SPRAGUE-DAWLEY;

EID: 41649112534     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/bjp.2008.27     Document Type: Article

References (77)

1. Abdul Aziz AA, Finn DP, Mason R, Chapman V (2005). Comparison of responses of ventral posterolateral and posterior complex thalamic neurons in naive rats and rats with hindpaw inflammation: mu-opioid receptor mediated inhibitions. Neuropharmacology 48: 607-616.
2. Apkarian AV, Shi T (1994). Squirrel monkey lateral thalamus. I. Somatic nociresponsive neurons and their relation to spinothalamic terminals. J Neurosci 14: 6779-6795.
3. Attal N, Cruccu G, Haanpaa M, Hansson P, Jensen TS, Nurmikko T et al. (2006). EFNS Task Force. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol 13: 1153-1169.
4. Backonja M, Beydoun A, Edwards KR, Schwartz SL, Fonseca V, Hes M et al. (1998). Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA 280: 1831-1836.
5. Basbaum AI, Fields HL (1984). Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Annu Rev Neurosci 7: 309-338.
6. Behbehani MM (1995). Functional characteristics of the midbrain periaqueductal gray. Prog Neurobiol 46: 575-605.
7. Bennett MI, Simpson KH (2004). Gabapentin in the treatment of neuropathic pain. Palliat Med 18: 5-11.
8. Bordi F, Quartaroli M (2000). Modulation of nociceptive transmission by NMDA/glycine site receptor in the ventroposterolateral nucleus of the thalamus. Pain 84: 213-224.
9. Chapman V, Suzuki R, Chamarette HL, Rygh LJ, Dickenson AH (1998). Effects of systemic carbamazepine and gabapentin on spinal neuronal responses in spinal nerve ligated rats. Pain 75: 261-272.
10. 2+ channels, KATP channels or N-methyl-D-aspartic acid receptors? Anesth Analg 102: 182-187.
11. Cheng JK, Chiou LC (2006). Mechanisms of the antinociceptive action of gabapentin. J Pharmacol Sci 100: 471-486.
12. Chizh BA, Scheede M, Schlutz H (2000). Antinociception and (R,S)-alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid antagonism by gabapentin in the rat spinal cord in vivo. Naunyn Schmiedebergs Arch Pharmacol 362: 197-200.
13. Coderre TJ, Kumar N, Lefebvre CD, Yu JS (2007). A comparison of the glutamate release inhibition and anti-allodynic effects of gabapentin, lamotrigine, and riluzole in a model of neuropathic pain. J Neurochem 100: 1289-1299.
14. Cole RL, Lechner SM, Williams ME, Prodanovich P, Bleicher L, Varney MA et al. (2005). Differential distribution of voltage-gated calcium channel alpha-2 delta (alpha2delta) subunit mRNA-containing cells in the rat central nervous system and the dorsal root ganglia. J Comp Neurol 491: 246-269.
15. Craig Jr AD, Burton H (1981). Spinal and medullary lamina I projection to nucleus submedius in medial thalamus: a possible pain center. J Neurophysiol 45: 443-466.
16. Dixon AL, Prior M, Morris PM, Shah YB, Joseph MH, Young AM (2005). Dopamine antagonist modulation of amphetamine response as detected using pharmacological MRI. Neuropharmacology 48: 236-245.
17. (+)-evoked glutamate release from rat neocortical and hippocampal slices by gabapentin. Neurosci Lett 280: 107-110.
18. 2+ channel alpha2delta ligands: novel modulators of neurotransmission. Trends Pharmacol Sci 28: 75-82.
19. Dostrovsky JO, Guilbaud G (1990). Nociceptive responses in medial thalamus of the normal and arthritic rat. Pain 40: 93-104.
20. Eckhardt K, Ammon S, Hofmann U, Riebe A, Gugeler N, Mikus G (2000). Gabapentin enhances the analgesic effect of morphine in healthy volunteers. Anesth Analg 91: 185-191.
21. Fardin V, Oliveras JL, Besson JM (1984a). A reinvestigation of the analgesic effects induced by stimulation of the periaqueductal gray matter in the rat. I. The production of behavioral side effects together with analgesia. Brain Res 306: 105-112.
22. Fardin V, Oliveras JL, Besson JM (1984b). A reinvestigation of the analgesic effects induced by stimulation of the periaqueductal gray matter in the rat. II. Differential characteristics of the analgesia induced by ventral and dorsal PAG stimulation. Brain Res 306: 125-139.
23. Feng Y, Cui M, Willis WD (2003). Gabapentin markedly reduces acetic acid-induced visceral nociception. Anesthesiology 98: 729-733.
24. Field MJ, Hughes J, Singh L (2000). Further evidence for the role of the alpha(2)delta subunit of voltage dependent calcium channels in models of neuropathic pain. Br J Pharmacol 131: 282-286.
25. Field MJ, McCleary S, Hughes J, Singh L (1999). Gabapentin and pregabalin, but not morphine and amitriptyline, block both static and dynamic components of mechanical allodynia induced by streptozocin in the rat. Pain 80: 391-398.
26. Fields HL (2000). Pain modulation: expectation, opioid analgesia and virtual pain. Prog Brain Res 122: 245-253.
27. Fox A, Gentry C, Patel S, Kesingland A, Bevan S (2003). Comparative activity of the anti-convulsants oxcarbazepine, carbamazepine, lamotrigine and gabapentin in a model of neuropathic pain in the rat and guinea-pig. Pain 105: 355-362.
28. Gauriau C, Bernard JF (2002). Pain pathways and parabrachial circuits in the rat. Exp Physiol 87: 251-258.
29. Gee NS, Brown JP, Dissanayake VU, Offord J, Thurlow R, Woodruff GN (1996). The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel. J Biol Chem 271: 5768-5776.
30. Guilbaud G (1985). Thalamic nociceptive systems. Philos Trans R Soc Lond B Biol Sci 308: 339-345.
31. Hempenstall K, Nurmikko TJ, Johnson RW, A'Hern RP, Rice AS (2005). Analgesic therapy in postherpetic neuralgia: a quantitative systematic review. PLoS Med 2: e164.
32. Hennig J, Nauerth A, Friedburg H (1986). RARE imaging: a fast imaging method for clinical MR. Magn Reson Med 3: 823-833.
33. Hulsebosch CE, Xu GY, Perez-Polo JR, Westlund KN, Taylor CP, McAdoo DJ (2000). Rodent model of chronic central pain after spinal cord contusion injury and effects of gabapentin. J Neurotrauma 17: 1205-1217.
34. Hunter JC, Gogas KR, Hedley LR, Jacobson LO, Kassotakis L, Thompson J et al. (1997). The effect of novel anti-epileptic drugs in rat experimental models of acute and chronic pain. Eur J Pharmacol 324: 153-160.
35. Hwang JH, Yaksh TL (1997). Effect of subarachnoid gabapentin on tactile-evoked allodynia in a surgically induced neuropathic pain model in the rat. Reg Anesth 22: 249-256.
36. Iannetti GD, Zambreanu L, Wise RG, Buchanan TJ, Huggins JP, Smart TS et al. (2005). Pharmacological modulation of pain-related brain activity during normal and central sensitization states in humans. Proc Natl Acad Sci USA 102: 18195-18200.
37. Jones DL, Sorkin LS (1998). Systemic gabapentin and S(+)-3-isobutyl- gamma-aminobutyric acid block secondary hyperalgesia. Brain Res 810: 93-99.
38. Jones MW, Apkarian AV, Stevens RT, Hodge Jr CJ (1987). The spinothalamic tract: an examination of the cells of origin of the dorsolateral and ventral spinothalamic pathways in cats. J Comp Neurol 260: 349-361.
39. Joshi SK, Hernandez G, Mikusa JP, Zhu CZ, Zhong C, Salyers A et al. (2006). Comparison of antinociceptive actions of standard analgesics in attenuating capsaicin and nerve-injury-induced mechanical hypersensitivity. Neuroscience 143: 587-596.
40. Jun JH, Yaksh TL (1998). The effect of intrathecal gabapentin and 3-isobutyl gamma-aminobutyric acid on the hyperalgesia observed after thermal injury in the rat. Anesth Analg 86: 348-354.
41. Klugbauer N, Marais E, Hofmann F (2003). Calcium channel alpha2delta subunits: differential expression, function, and drug binding. J Bioenerg Biomembr 35: 639-644.
42. Krout KE, Loewy AD (2000). Periaqueductal gray matter projections to midline and intralaminar thalamic nuclei of the rat. J Comp Neurol 424: 111-141.
43. Lanneau C, Green A, Hirst WD, Wise A, Brown JT, Donnier E et al. (2001). Gabapentin is not a GABAB receptor agonist. Neuropharmacology 41: 965-975.
44. Li CY, Song YH, Higuera ES, Luo ZD (2004). Spinal dorsal horn calcium channel α2δ-1 subunit upregulation contributes to peripheral nerve injury-induced tactile allodynia. J Neurosci 24: 8494-8499.
45. Light AR, Perl ER (1979a). Reexamination of the dorsal root projection to the spinal dorsal horn including observations on the differential termination of coarse and fine fibers. J Comp Neurol 186: 117-131.
46. Light AR, Perl ER (1979b). Spinal termination of functionally identified primary afferent neurons with slowly conducting myelinated fibers. J Comp Neurol 186: 133-150.
47. Ling B, Authier N, Balayssac D, Eschalier A, Coudore F (2007). Behavioral and pharmacological description of oxaliplatin-induced painful neuropathy in rat. Pain 128: 225-234.
48. Luer MS, Hamani C, Dujovny M, Gidal B, Cwik M, Deyo K et al. (1999). Saturable transport of gabapentin at the blood-brain barrier. Neurol Res 21: 559-562.
49. Luo ZD, Calcutt NA, Higuera ES, Valder CR, Song YH, Svensson CI et al. (2002). Injury type-specific calcium channel α2δ-1 subunit up-regulation in rat neuropathic pain models correlates with antiallodynic effects of gabapentin. J Pharmacol Exp Ther 303: 1199-1205.
50. Lynch III JJ, Wade CL, Zhong CM, Mikusa JP, Honore P (2004). Attenuation of mechanical allodynia by clinically utilized drugs in a rat chemotherapy-induced neuropathic pain model. Pain 110: 56-63.
51. Mackensen GB, Sato Y, Nellgard B, Pineda J, Newman MF, Warner DS et al. (2001). Cardiopulmonary bypass induces neurologic and neurocognitive dysfunction in the rat. Anesthesiology 95: 1485-1491.
52. Marais E, Klugbauer N, Hofmann F (2001). Calcium channel alpha(2)delta subunits-structure and gabapentin binding. Mol Pharmacol 59: 1243-1248.
53. Martin WJ, Hohmann AG, Walker JM (1996). Suppression of noxious stimulus-evoked activity in the ventral posterolateral nucleus of the thalamus by a cannabinoid agonist: correlation between electrophysiological and antinociceptive effects. J Neurosci 16: 6601-6611.
54. Matthews EA, Dickenson AH (2001). Effects of spinally delivered N-and P-type voltage-dependent calcium channel antagonists on dorsal horn neuronal responses in a rat model of neuropathy. Pain 92: 235-246.
55. Mayer DJ, Wolfle TL, Akil H, Carder B, Liebeskind JC (1971). Analgesia from electrical stimulation in the brainstem of the rat. Science 174: 1351-1354.
56. Morgan MM, Gold MS, Liebeskind JC, Stein C (1991). Periaqueductal gray stimulation produces a spinally mediated, opioid antinociception for the inflamed hindpaw of the rat. Brain Res 545: 17-23.
57. Morgan MM, Sohn JH, Liebeskind JC (1989). Stimulation of the periaqueductal gray matter inhibits nociception at the supraspinal as well as spinal level. Brain Res 502: 61-66.
58. Moylan Governo RJ, Morris PG, Prior MJ, Marsden CA, Chapman V (2006). Capsaicin-evoked brain activation and central sensitization in anaesthetised rats: a functional magnetic resonance imaging study. Pain 126: 35-45.
59. Ng GY, Bertrand S, Sullivan R, Ethier N, Wang J, Yergey J et al. (2001). Gamma-aminobutyric acid type B receptors with specific heterodimer composition and postsynaptic actions in hippocampal neurons are targets of anticonvulsant gabapentin action. Mol Pharmacol 59: 144-152.
60. Nicolas LB, Klein S, Prinssen EP (2007). Defensive-like behaviors induced by ultrasound: further pharmacological characterization in Lister-hooded rats. Psychopharmacology 194: 243-252.
61. Parker DA, Ong J, Marino V, Kerr DI (2004). Gabapentin activates presynaptic GABAB heteroreceptors in rat cortical slices. Eur J Pharmacol 495: 137-143.
62. Paxinos G, Watson C (1998). The Rat Brain in Stereotaxic Coordinates. Academic Press: New York.
63. Rice AS, Maton S (2001). Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study. Pain 94: 215-224.
64. Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller L (1998). Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA 280: 1837-1842.
65. Shah YB, Haynes L, Prior MJ, Marsden CA, Morris PG, Chapman V (2005). Functional magnetic resonance imaging studies of opioid receptor-mediated modulation of noxious-evoked BOLD contrast in rats. Psychopharmacology (Berl) 180: 761-773.
66. Shah YB, Prior MJ, Dixon AL, Morris PG, Marsden CA (2004). Detection of cannabinoid agonist evoked increase in BOLD contrast in rats using functional magnetic resonance imaging. Neuropharmacology 46: 379-387.
67. Shimoyama M, Shimoyama N, Hori Y (2000). Gabapentin affects glutamatergic excitatory neurotransmission in the rat dorsal horn. Pain 85: 405-414.
68. Siggaard-Andersen O (1971). An acid-base chart for arterial blood with normal and pathophysiological reference areas. Scand J Clin Lab Invest 27: 239-245.
69. Sills GJ (2006). The mechanisms of action of gabapentin and pregabalin. Curr Opin Pharmacol 6: 108-113.
70. Stanfa LC, Singh L, Williams RG, Dickenson AH (1997). Gabapentin, ineffective in normal rats, markedly reduces C-fibre evoked responses after inflammation. Neuroreport 8: 587-590.
71. van Hooft JA, Dougherty JJ, Endeman D, Nichols RA, Wadman WJ (2002). Gabapentin inhibits presynaptic Ca(2+) influx and synaptic transmission in rat hippocampus and neocortex. Eur J Pharmacol 449: 221-228.
72. Vollmer KO, von Hodenberg A, Kolle EU (1986). Pharmacokinetics and metabolism of gabapentin in rat, dog and man. Arzneimittelforschung 36: 830-839.
73. Wade AR (2002). The negative BOLD signal unmasked. Neuron 36: 993-995.
74. Worsley KJ, Friston KJ (1995). Analysis of fMRI time-series revisited-again. Neuroimage 2: 173-181.
75. Xiao W, Boroujerdi A, Bennett GJ, Luo ZD (2007). Chemotherapy-evoked painful peripheral neuropathy: analgesic effects of gabapentin and effects on expression of the alpha-2-delta type-1 calcium channel subunit. Neuroscience 144: 714-720.
76. Yamamoto T, Sakashita Y (1998). Differential effects of intrathecally administered N- and P-type voltage-sensitive calcium channel blockers upon two models of experimental mononeuropathy in the rat. Brain Res 794: 329-332.
77. Yoon MH, Choi JI (2003). Hemodynamic effects of gabapentin in rats. J Korean Med Sci 18: 478-482.